Retraction: Use of tiotropium bromide for pre-operative treatment in chronic obstructive pulmonary disease patients: comparison with oxitropium bromide.

This paper was withdrawn by the authors due to the inclusion of incorrect experimental data.

[1]  Nicholas J Gross,et al.  Tiotropium Bromide , 2012 .

[2]  C. Incorvaia,et al.  Effects of replacing oxitropium with tiotropium on pulmonary function in patients with COPD: a randomized study. , 2007, Respiratory medicine.

[3]  C. Wentworth,et al.  Pooled clinical trial analysis of tiotropium safety. , 2006, Chest.

[4]  D. D. Briggs,et al.  Tiotropium in COPD patients not previously receiving maintenance respiratory medications. , 2006, Respiratory medicine.

[5]  S. Ramsey,et al.  Chronic obstructive pulmonary disease, risk factors, and outcome trials: comparisons with cardiovascular disease. , 2006, Proceedings of the American Thoracic Society.

[6]  Giovanni Viegi,et al.  Epidemiology of chronic obstructive pulmonary disease: Health effects of air pollution , 2006, Respirology.

[7]  R. Perng,et al.  Additive benefits of tiotropium in COPD patients treated with long‐acting β2 agonists and corticosteroids , 2006, Respirology.

[8]  N. Colabianchi,et al.  Laryngeal cancer and gastroesophageal reflux disease: a case-control study. , 2006, The American journal of medicine.

[9]  P. Lopez,et al.  Esophageal cancer: a review and update. , 2006, American family physician.

[10]  K. Arimura,et al.  Effects of omega-3 polyunsaturated fatty acids on inflammatory markers in COPD. , 2005, Chest.

[11]  D. Niewoehner,et al.  Prevention of Exacerbations of Chronic Obstructive Pulmonary Disease with Tiotropium, a Once-Daily Inhaled Anticholinergic Bronchodilator , 2005, Annals of Internal Medicine.

[12]  C. Viscoli,et al.  Major Risk Factors for Intracerebral Hemorrhage in the Young Are Modifiable , 2005, Stroke.

[13]  Alan D. Lopez,et al.  Role of Smoking in Global and Regional Cardiovascular Mortality , 2005, Circulation.

[14]  P. Paré,et al.  Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis , 2005, Thorax.

[15]  A. Iyoda,et al.  Perioperative rehabilitation and physiotherapy for lung cancer patients with chronic obstructive pulmonary disease. , 2005, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.

[16]  R. Casaburi,et al.  Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. , 2005, Chest.

[17]  M. Nishimura,et al.  COPD in Japan: the Nippon COPD Epidemiology study , 2004, Respirology.

[18]  W. MacNee,et al.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.

[19]  E. Salpeter,et al.  Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. , 2004, Chest.

[20]  W. Willett,et al.  Dietary Carotenoids and Risk of Lung Cancer in a Pooled Analysis of Seven Cohort Studies , 2004, Cancer Epidemiology Biomarkers & Prevention.

[21]  M. Blaser,et al.  Population attributable risks of esophageal and gastric cancers. , 2003, Journal of the National Cancer Institute.

[22]  R. Sansores,et al.  Effect of the combination of two bronchodilators on breathlessness in patients with chronic obstructive pulmonary disease. A crossover clinical trial. , 2003, Archives of medical research.

[23]  A. Lumsden,et al.  Epidural Analgesia in Patients with Chronic Obstructive Pulmonary Disease Undergoing Transperitoneal Abdominal Aortic Aneurysmorraphy — A Multi-Institutional Analysis , 2003, Cardiovascular surgery.

[24]  D Olivieri,et al.  Efficacy and safety of oxitropium bromide, theophylline and their combination in COPD patients: a double-blind, randomized, multicentre study (BREATH Trial). , 2002, Respiratory medicine.

[25]  E. Bateman,et al.  A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. , 2002, Chest.

[26]  T. Fujisawa,et al.  Impact of COPD on pulmonary complications and on long-term survival of patients undergoing surgery for NSCLC. , 2002, Lung cancer.

[27]  P. Bonde,et al.  Lung surgery: identifying the subgroup at risk for sputum retention. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[28]  R. Zuwallack,et al.  A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease , 2002, European Respiratory Journal.

[29]  Y. Sekine,et al.  COPD may increase the incidence of refractory supraventricular arrhythmias following pulmonary resection for non-small cell lung cancer. , 2001, Chest.

[30]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[31]  J Bousquet,et al.  Asthma. From bronchoconstriction to airways inflammation and remodeling. , 2000, American journal of respiratory and critical care medicine.

[32]  M. Littner,et al.  Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[33]  Mathews Jt,et al.  Respiratory complications in postoperative patients. , 1999 .

[34]  L. Goffi,et al.  Preoperative APACHE II and ASA scores in patients having major general surgical operations: prognostic value and potential clinical applications. , 1999, The European journal of surgery = Acta chirurgica.

[35]  T. Witek,et al.  Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease. , 1999, Life sciences.

[36]  Y. Mc,et al.  Bladder cancer epidemiology and pathogenesis. , 1996 .

[37]  M. Schell,et al.  Factors Associated with Postoperative Pulmonary Complications in Patients with Severe Chronic Obstructive Pulmonary Disease , 1995, Anesthesia and analgesia.

[38]  J. Earis,et al.  Acute bronchodilator trials in chronic obstructive pulmonary disease. , 1992, The American review of respiratory disease.

[39]  V. Lawrence,et al.  Operative risk in patients with severe obstructive pulmonary disease. , 1992, Archives of internal medicine.

[40]  T. Reilley,et al.  Analysis of risk factors for postoperative pulmonary complications in head and neck surgery , 1992, The Laryngoscope.

[41]  P. Jones,et al.  The St George's Respiratory Questionnaire. , 1991, Respiratory medicine.

[42]  J. Hall,et al.  A multivariate analysis of the risk of pulmonary complications after laparotomy. , 1991, Chest.

[43]  F. Grover,et al.  Initial report of the Veterans Administration Preoperative Risk Assessment Study for Cardiac Surgery. , 1990, The Annals of thoracic surgery.

[44]  N. Gross,et al.  Cholinergic bronchomotor tone in COPD. Estimates of its amount in comparison with that in normal subjects. , 1989, Chest.

[45]  R. Patterson,et al.  Minimal complications in a surgical population with severe asthma receiving prophylactic corticosteroids. , 1988, The Journal of allergy and clinical immunology.

[46]  J. Nunn,et al.  Criteria of fitness for anaesthesia in patients with chronic obstructive lung disease. , 1975, British medical journal.

[47]  J. Myburgh,et al.  Tissue Typing, Antilymphocyte Globulin, and Prophylactic Graft Irradiation in Cadaver Kidney Transplantation , 1970, British medical journal.

[48]  D. R. Jones.  Predictors of operative mortality and cardiopulmonary morbidity in the National Emphysema Treatment Trial , 2007 .

[49]  B. Berktaş,et al.  Risk factors associated with postoperative pulmonary complications following oncological surgery. , 2004, Tuberkuloz ve toraks.

[50]  ATS statement: guidelines for the six-minute walk test. , 2002, American journal of respiratory and critical care medicine.

[51]  P. Jones,et al.  Bladder cancer epidemiology and pathogenesis. , 1996, Seminars in oncology.

[52]  Phillips Yy,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. , 1987, The American review of respiratory disease.